Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus

British Journal of Pharmacology

Volumn 151, Issue 7, 2007, Pages 1109-1116

  Soria Gomez E ^a   Matias, I ^b   Rueda Orozco, P E ^a   Cisneros, M ^a   Petrosino, S ^b   Navarro, L ^a   Di Marzo, V ^b   Prospero Garcia O ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b CNR   (Italy)

Author keywords

Anandamide; Anandamide transporter; Cannabinoid receptor 1; FAAH; Hyperphagia; Hypothalamus; Nucleus accumbens shell

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; APPETITE STIMULANT; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; N ARACHIDONOYL SEROTONIN; N OLEOYL (1' HYDROXYBENZYL) 2' ETHANOLAMINE; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; ARCUATE NUCLEUS; BENZYL COMPOUNDS; EATING; ENDOCANNABINOIDS; GLYCERIDES; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NUCLEUS ACCUMBENS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PROTO-ONCOGENE PROTEINS C-FOS; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SEROTONIN; TIME FACTORS;

EID: 34547574943     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707313     Document Type: Article

References (50)

1. Bali B, Kovács KJ (2003). GABAergic control of neuropeptide gene expression in parvocellular neurons of the hypothalamic paraventricular nucleus. Eur J Neurosci 18: 1518-1526.
2. Bellinger LL, Bernardis LL (2002). The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiol Behav 76: 431-442.
3. Berthoud HR (2004). Mind versus metabolism in the control of food intake and energy balance. Physiol Behav 81: 781-793.
4. Bisogno T, Melck D, De Petrocellis L, Bobrov MY, Gretskaya NM, Bezuglov VV et al. (1998). Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 248: 515-522.
5. Chambers AP, Sharkey KA, Koopmans HS (2004). Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat. Physiol Behav 82: 863-869.
6. Christie MJ (2006). Opioid and cannabinoid receptors: friends with benefits or just close friends? Br J Pharmacol 148: 385-386.
7. Cooper SJ (2004). Endocannabinoids and food consumption: comparison with benzodiazepine and opioid palatability-dependent appetite. Eur J Pharmacol 500: 37-49.
8. Cota D, Marsicano G, Tschp̂ M, Gŗbler Y, Flachskman C, Schubert M et al. (2003). The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423-431.
9. Cota D, Tschop MH, Horvath TL, Levine AS (2006). Cannabinoids, opioids, and eating behavior: the molecular face of hedonism. Brain Res Rev 51: 85-107.
10. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkal S, JAral Z et al. (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825.
11. Di Marzo V, Matias I (2005). Endocannabinoid control of food intake and energy balance. Nat Neurosc 8: 585-589.
12. Fride E, Bregman T, Kirkham TC (2005). Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Exp Biol Med 230: 225-234.
13. Gamber KM, Macarthur H, Westfall TC (2005). Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 49: 646-652.
14. Gooley JJ, Schomer A, Saper CB (2006). The dorsomedial hypothalamic nucleus is critical for the expression of food-entrainable circadian rhythms. Nat Neurosci 9: 398-407.
15. Hanlon EC, Baldo BA, Sadeghian K, Kelley AE (2004). Increase in food intake or food seeking behavior induced by GABAergic, opioid, or dopaminergic stimulation of the nucleus accumbens: is it hunger? Psychopharmacology 172: 241-247.
16. Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003). Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462: 125-132.
17. Hoffman AF, Lupica CR (2000). Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysio 85: 72-83.
18. Jamshidi N, Taylor DA (2001). Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134: 1151-1154.
19. Jo YH, Chen YJ, Chua Jr C, Talmage DA, Role LW (2005). Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48: 1055-1066.
20. Kelley AE (2004). Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 27: 765-776.
21. Kelley AE, Swanson CJ (1997). Feeding induced by blockade of AMPA and kainite receptors within the ventral striatum: a microinfusion mapping study. Behav Brain Res 89: 107-113.
22. Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002). Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136: 550-557.
23. Lupica CR, Riegel AC, Hoffman AF (2004). Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 143: 227-234.
24. MacDonald AF, Billington CJ, Levine AS (2003). Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am J Physiol Regul Integr Comp Physiol 285: 999-1004.
25. Maldonado-Irizarry CS, Swanson CJ, Kelley AE (1995). Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 15: 6779-6788.
26. Manzoni OJ, Bockaert J (2001). Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur J Pharmacol 412: R3-R5.
27. Martinez-Gonzalez D, Bonilla-Jaime H, Morales-Otal A, Henriksen SJ, Velazquez-Moctezuma J, Prospero-Garcia O (2004). Oleamide and anandamide effects on food intake and sexual behavior of rats. Neurosci Lett 364: 1-6.
28. Miller CC, Murray TF, Freeman KG, Edwards GL (2004). Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. Physiol Behav 80: 611-616.
29. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006). Central nervous system control of food intake and body weight. Nature 443: 289-295.
30. Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V (2003). Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65: 1473-1481.
31. Osei-Hyiaman D, Depetrillo M, Harvey-White J, Bannon AW, Cravatt BF, Kuhar MJ et al. (2005a). Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of the endogenous anandamide. Neuroendocrinology 81: 273-282.
32. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S et al. (2005b). Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115: 1298-1305.
33. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Raven Press: New York, NY.
34. Peciña S, Berridge KC (2005). Hedonic hot spot in nucleus accumbens shell: where do m-opioids caused increased hedonic impact of sweetness? J Neusci 25: 11777-11786.
35. Pistis M, Muntoni AL, Pillolla G, Gessa GL (2002). Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur J Neurosci 15: 1795-1802.
36. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ (2002). Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99: 8384-8388.
37. Serrano A, del Arco I, Pavón FJ, Macías M, Perez-Valero V, Rodríguez de Fonseca F. (2007). The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long term treatment with oleoylethanolamide in Zucker rats. Neuropharmacology (in press, available online 24 March 2007).
38. Söderpalm AH, Berridge KC (2000). Food intake after diazepam, morphine or muscimol: microinjections in the nucleus accumbens shell. Pharmacol Biochem Behav 66: 429-434.
39. Stratford TR, Kelley AE (1997). GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J Neurosci 17: 4434-4440.
40. Stratford TR, Kelley AE (1999). Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 19: 11040-11048.
41. Stratford TR, Swanson CJ, Kelley AE (1998). Specific changes in food intake elicited by blockade or activation of glutamate receptors in the nucleus accumbens shell. Behav Brain Res 93: 43-50.
42. Tucci SA, Rogers EK, Korbonits M, Kirkham TC (2004). The cannabinoid CB1 receptor antagonist SR141716A blocks the orexigenic effects of intrahypothalamic ghrelin. Br J Pharmacol 143: 520-523.
43. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, RIO-Europe Study Group (2005). Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365: 1389-1397.
44. Vigano D, Rubino T, Parolaro D (2005). Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacol Biochem Behav 81: 360-368.
45. Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A et al. (2005). CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 145: 293-300.
46. Will MJ, Franzblau EB, Kelley AE (2003). Nucleus accumbens μ-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 23: 2882-2888.
47. Williams CM, Kirkham TC (1999). Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143: 315-317.
48. 9-THC and anandamide. Physiol Behav 76: 241-250.
49. Wynne K, Stanley S, McGowan B, Bloom S (2005). Appetite control. J Endocrinol 184: 291-318.
50. Zhang H, Corkern M, Stoyanova I, Patterson LM, Tian R, Berthoud HR (2003). Appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons. Am J Physiol Regul Integr Comp Physiol 284: R1436-R1444.